Researchers retrospectively reviewed the records of a series of patients who underwent onabotulinumtoxinA (Botox) injections for overactive bladder from 2007 to 2017.
Nocturnal polyuria can't be diagnosed using a standard history alone, researchers say.
Many urologists don't follow guidelines calling on them to image their patients after ureteroscopic stone disease treatment, researchers say.
A new frailty assessment tool can aid in the prognosis of urologic cancer patients, its inventors say.
OnabotulinumtoxinA (Botox) appears to increase the activity of brain regions involved in sensation and processing of urinary urgency in female patients with neurogenic overactive bladder, says Rose Khavari, MD.
Among 321 scheduled telemedicine visits for patients with neurogenic bladder, the compliance rate was 91%.
Nephron-sparing procedures now have clear advantages over radical nephrectomy for most small renal masses.
Las Vegas—The best way to treat premature ejaculation (PE) is through a combination of sex therapy and pharmaceutical management, Michael A. Perelman, PhD, argued at the Sexual Medicine Society of North America fall meeting here.
Las Vegas—Middle-aged men with erectile dysfunction may benefit from penile microvascular arterial bypass surgery as much as young men do, Boston University researchers reported at the Sexual Medicine Society of North America fall meeting here.
Las Vegas—Most men with erectile dysfunction should be tested for androgen deficiency, according to researchers from the University of Minnesota Medical School, Minneapolis. In their study of men with erectile dysfunction, nearly half had testosterone levels less than 400 ng/dL, but they cautioned that the results did not suggest a cause-effect relationship.